While the role of ATRX deficiency in the alternative lengthening of telomeres pathway is well described in sarcomas and other ATRX deficient cancers, the chromatin-specific consequences of ATRX loss are not fully understood in the context of disease mechanisms (12,13). The gene discussed is ATRX; the disease is sarcoma.